Skip to main content
Erschienen in:

15.04.2024 | Original Article

Effect of revised organ transplant law in Japan on lung transplantation

verfasst von: Yoshito Imamura, Daisuke Nakajima, Takashi Kanou, Yasushi Shintani, Seiichiro Sugimoto, Shinichi Toyooka, Yasushi Hoshikawa, Keitaro Matsumoto, Takeshi Nagayasu, Hidemi Suzuki, Sumiko Maeda, Masayuki Chida, Takeshi Shiraishi, Toshihiko Sato, Masaaki Sato, Jun Nakajima, Hisashi Oishi, Yoshinori Okada, Hiroshi Date

Erschienen in: Surgery Today | Ausgabe 10/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate how revision of the organ transplant law in Japan affected lung transplantation in this country.

Methods

Lung transplant candidates registered between January, 2000 and December, 2009 were designated as the pre-revision group (n = 396) and those registered between January, 2011 and December, 2020, as the post-revision group (n = 1326). Both groups were analyzed retrospectively using data collected by the Japanese Society of Lung and Heart–Lung Transplantation.

Results

The number of patients who underwent brain-dead donor lung transplantation (BDLT) increased significantly after the law amendment (32.2 vs. 13.8%, p < 0.01). The median waiting time for BDLT was significantly reduced (708 days vs. 1163 days, p < 0.01) and the mortality rate while waiting for BDLT improved significantly after the law amendment (33.1 vs. 42.6%, p < 0.01). In the post-revision group, 18 pediatric patients underwent BDLT. The 5-year survival rates after BDLT were comparable between the groups (73.5% in the pre-revision group vs. 73.2% in the post-revision group, p = 0.32).

Conclusions

The organ transplant law revision shortened the waiting time for BDLT significantly and decreased the mortality rate while waiting for BDLT. The posttransplant outcomes in Japan remained favorable throughout the study period.
Literatur
1.
Zurück zum Zitat Chambers DC, Perch M, Zuckermann A, Cherikh WS, Harhay MO, Hayes D, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-eighth adult lung transplantation report—2021; Focus on recipient characteristics. J Heart Lung Transplant. 2021;40:1060–72.CrossRefPubMedPubMedCentral Chambers DC, Perch M, Zuckermann A, Cherikh WS, Harhay MO, Hayes D, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-eighth adult lung transplantation report—2021; Focus on recipient characteristics. J Heart Lung Transplant. 2021;40:1060–72.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Date H, Aoe M, Nagahiro I, Sano Y, Andou A, Matsubara H, et al. Living-donor lobar lung transplantation for various lung diseases. J Thorac Cardiovasc Surg. 2003;126:476–81.CrossRefPubMed Date H, Aoe M, Nagahiro I, Sano Y, Andou A, Matsubara H, et al. Living-donor lobar lung transplantation for various lung diseases. J Thorac Cardiovasc Surg. 2003;126:476–81.CrossRefPubMed
3.
Zurück zum Zitat Okada Y, Chida M, Nakajima J, Yoshino I, Shintani Y, Oto T, et al. Current status of lung transplantation in Japan—report from Japanese lung transplant registry. J Vis Surg. 2021;7:13.CrossRef Okada Y, Chida M, Nakajima J, Yoshino I, Shintani Y, Oto T, et al. Current status of lung transplantation in Japan—report from Japanese lung transplant registry. J Vis Surg. 2021;7:13.CrossRef
5.
Zurück zum Zitat Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRefPubMed Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRefPubMed
6.
Zurück zum Zitat Valapour M, Lehr CJ, Skeans MA, Smith JM, Miller E, Goff R, et al. OPTN/SRTR 2019 annual data report: lung. Am J Transplant. 2021;21:441–520.CrossRefPubMed Valapour M, Lehr CJ, Skeans MA, Smith JM, Miller E, Goff R, et al. OPTN/SRTR 2019 annual data report: lung. Am J Transplant. 2021;21:441–520.CrossRefPubMed
7.
Zurück zum Zitat Stehlik J, Stevenson LW, Edwards LB, Crespo-Leiro MG, Delgado JF, Dorent R, et al. Organ allocation around the world: insights from the ISHLT international registry for heart and lung transplantation. J Heart Lung Transplant. 2014;33:975–84.CrossRefPubMed Stehlik J, Stevenson LW, Edwards LB, Crespo-Leiro MG, Delgado JF, Dorent R, et al. Organ allocation around the world: insights from the ISHLT international registry for heart and lung transplantation. J Heart Lung Transplant. 2014;33:975–84.CrossRefPubMed
8.
Zurück zum Zitat Hirama T, Akiba M, Watanabe T, Watanabe Y, Notsuda H, Oishi H, et al. Waiting time and mortality rate on lung transplant candidates in Japan: a single-center retrospective cohort study. BMC Pulm Med. 2021;21:390.CrossRefPubMedPubMedCentral Hirama T, Akiba M, Watanabe T, Watanabe Y, Notsuda H, Oishi H, et al. Waiting time and mortality rate on lung transplant candidates in Japan: a single-center retrospective cohort study. BMC Pulm Med. 2021;21:390.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Oishi H, Okada Y, Sato M, Nakajima J, Nakajima D, Shiraishi T, et al. Prognostic factors for lung transplant recipients focusing on age and gender: the Japanese lung transplantation report 2022. Surg Today. 2023;53:1188–98.CrossRefPubMedPubMedCentral Oishi H, Okada Y, Sato M, Nakajima J, Nakajima D, Shiraishi T, et al. Prognostic factors for lung transplant recipients focusing on age and gender: the Japanese lung transplantation report 2022. Surg Today. 2023;53:1188–98.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Van Raemdonck D, Keshavjee S, Levvey B, Cherikh WS, Snell G, Erasmus M, et al. Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT Registry. J Heart Lung Transplant. 2019;38:1235–45.CrossRefPubMed Van Raemdonck D, Keshavjee S, Levvey B, Cherikh WS, Snell G, Erasmus M, et al. Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT Registry. J Heart Lung Transplant. 2019;38:1235–45.CrossRefPubMed
11.
Zurück zum Zitat Starnes VA, Woo MS, MacLaughlin EF, Horn MV, Wong PC, Rowland KM, et al. Comparison of outcomes between living donor and cadaveric lung transplantation in children. Ann Thorac Surg. 1999;68:2279–83 (Discussion 2283-4).CrossRefPubMed Starnes VA, Woo MS, MacLaughlin EF, Horn MV, Wong PC, Rowland KM, et al. Comparison of outcomes between living donor and cadaveric lung transplantation in children. Ann Thorac Surg. 1999;68:2279–83 (Discussion 2283-4).CrossRefPubMed
13.
Zurück zum Zitat Chen-Yoshikawa TF, Sugimoto S, Shiraishi T, Minami M, Matsuda Y, Chida M, et al. Prognostic factors in lung transplantation after hematopoietic stem cell transplantation. Transplantation. 2018;102:154–61.CrossRefPubMed Chen-Yoshikawa TF, Sugimoto S, Shiraishi T, Minami M, Matsuda Y, Chida M, et al. Prognostic factors in lung transplantation after hematopoietic stem cell transplantation. Transplantation. 2018;102:154–61.CrossRefPubMed
14.
Zurück zum Zitat Richeldi L, Cottin V, du Bois RM, Selman M, Kimura T, Bailes Z, et al. Nintedanib in patients with idiopathic pulmonary fibrosis: combined evidence from the TOMORROW and INPULSIS® trials. Respir Med. 2016;113:74–9.CrossRefPubMed Richeldi L, Cottin V, du Bois RM, Selman M, Kimura T, Bailes Z, et al. Nintedanib in patients with idiopathic pulmonary fibrosis: combined evidence from the TOMORROW and INPULSIS® trials. Respir Med. 2016;113:74–9.CrossRefPubMed
15.
Zurück zum Zitat Ikezoe K, Handa T, Tanizawa K, Chen-Yoshikawa TF, Kubo T, Aoyama A, et al. Prognostic factors and outcomes in Japanese lung transplant candidates with interstitial lung disease. PLoS ONE. 2017;12: e0183171.CrossRefPubMedPubMedCentral Ikezoe K, Handa T, Tanizawa K, Chen-Yoshikawa TF, Kubo T, Aoyama A, et al. Prognostic factors and outcomes in Japanese lung transplant candidates with interstitial lung disease. PLoS ONE. 2017;12: e0183171.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Leard LE, Holm AM, Valapour M, Glanville AR, Attawar S, Aversa M, et al. Consensus document for the selection of lung transplant candidates: An update from the International society for heart and lung transplantation. J Heart Lung Transplant. 2021;40:1349–79.CrossRefPubMedPubMedCentral Leard LE, Holm AM, Valapour M, Glanville AR, Attawar S, Aversa M, et al. Consensus document for the selection of lung transplant candidates: An update from the International society for heart and lung transplantation. J Heart Lung Transplant. 2021;40:1349–79.CrossRefPubMedPubMedCentral
Metadaten
Titel
Effect of revised organ transplant law in Japan on lung transplantation
verfasst von
Yoshito Imamura
Daisuke Nakajima
Takashi Kanou
Yasushi Shintani
Seiichiro Sugimoto
Shinichi Toyooka
Yasushi Hoshikawa
Keitaro Matsumoto
Takeshi Nagayasu
Hidemi Suzuki
Sumiko Maeda
Masayuki Chida
Takeshi Shiraishi
Toshihiko Sato
Masaaki Sato
Jun Nakajima
Hisashi Oishi
Yoshinori Okada
Hiroshi Date
Publikationsdatum
15.04.2024
Verlag
Springer Nature Singapore
Erschienen in
Surgery Today / Ausgabe 10/2024
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-024-02839-5

Neu im Fachgebiet Chirurgie

Op.-Entscheidung bei Divertikulitis: Lebensqualität zählt!

Soll man Menschen, die schon mehrfach schmerzhafte Divertikulitisepisoden durchgemacht haben, eine Op. anbieten? Ein Team aus Helsinki rät, dies von der Lebensqualität abhängig zu machen.

Akute Cholezystitis bei multimorbiden Älteren: Operation nicht sofort ausschließen!

Bei älteren, multimorbiden Menschen mit akuter Cholezystitis wird eine Operation häufig nicht erwogen. Eine Studie aus Philadelphia zeigt nun jedoch, dass auch diese Patientinnen und Patienten von einer chirurgischen Therapie profitieren können.

Was geschehen muss, damit Prähabilitation in die Leitlinien kommt

Eine Prähabilitation vor einem viszeralchirurgischen Eingriff ist Experten zufolge äußerst sinnvoll, dennoch wird sie in Leitlinien derzeit nicht empfohlen. Beim DCK erklärte Prof. Tim Vilz aus Bonn, woran das liegt und was benötigt wird, um die Situation zu ändern.

Thoracic-Outlet-Syndrom nur in Ausnahmefällen operieren!

Das Thoracic-Outlet-Syndrom erfordert nur in ganz bestimmten Fällen ein operatives Vorgehen. Beim DCK wurde vor schwerwiegenden Komplikationen des anspruchsvollen Eingriffs gewarnt.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.